Clinical and Genetic Characteristics in Patients With Gitelman Syndrome
- PMID: 30596175
- PMCID: PMC6308995
- DOI: 10.1016/j.ekir.2018.09.015
Clinical and Genetic Characteristics in Patients With Gitelman Syndrome
Abstract
Introduction: Gitelman syndrome (GS) is a tubulopathy exhibited by salt loss. GS cases are most often diagnosed by chance blood test. Aside from that, some cases are also diagnosed from tetanic symptoms associated with hypokalemia and/or hypomagnesemia or short stature. As for complications, thyroid dysfunction and short stature are known, but the incidence rates for these complications have not yet been elucidated. In addition, no genotype-phenotype correlation has been identified in GS.
Methods: We examined the clinical characteristics and genotype-phenotype correlation in genetically proven GS cases with homozygous or compound heterozygous variants in SLC12A3 (n = 185).
Results: In our cohort, diagnostic opportunities were by chance blood tests (54.7%), tetany (32.6%), or short stature (7.2%). Regarding complications, 16.3% had short stature, 13.7% had experienced febrile convulsion, 4.3% had thyroid dysfunction, and 2.5% were diagnosed with epilepsy. In one case, QT prolongation was detected. Among 29 cases with short stature, 10 were diagnosed with growth hormone (GH) deficiency and GH replacement therapy started. Interestingly, there was a strong correlation in serum magnesium levels between cases with p.Arg642Cys and/or p.Leu858His and cases without these variants, which are mutational hotspots in the Japanese population (1.76 mg/dl vs. 1.43 mg/dl, P < 0.001).
Conclusion: This study has revealed, for the first time, clinical characteristics in genetically proven GS cases in the Japanese population, including prevalence of complications. Patients with hypokalemia detected by chance blood test should have gene tests performed. Patients with GS need attention for developing extrarenal complications, such as short stature, febrile convulsion, thyroid dysfunction, epilepsy, or QT prolongation. It was also revealed for the first time that hypomagnesemia was not severe in some variants in SLC12A3.
Keywords: QT prolongation; SLC12A3; febrile convulsion; salt-losing tubulopathy; thyroid.
Figures
Similar articles
-
Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome.J Korean Med Sci. 2016 Jan;31(1):47-54. doi: 10.3346/jkms.2016.31.1.47. Epub 2015 Dec 24. J Korean Med Sci. 2016. PMID: 26770037 Free PMC article.
-
Gitelman syndrome combined with growth hormone deficiency: Three cases report.Medicine (Baltimore). 2019 Oct;98(40):e17244. doi: 10.1097/MD.0000000000017244. Medicine (Baltimore). 2019. PMID: 31577716 Free PMC article.
-
A NOVEL COMPOUND HETEROZYGOUS VARIANT OF SLC12A3 GENE IN A PEDIGREE WITH GITELMAN SYNDROME CO-EXISTENT WITH THYROID DYSFUNCTION.Endocr Pract. 2018 Oct 2;24(10):889-893. doi: 10.4158/EP-2018-0218. Epub 2018 Aug 7. Endocr Pract. 2018. PMID: 30084681
-
A novel compound heterozygous mutation of SLC12A3 gene in a pedigree with Gitelman syndrome and literature review.Genes Genomics. 2020 Sep;42(9):1035-1040. doi: 10.1007/s13258-020-00960-6. Epub 2020 Jul 25. Genes Genomics. 2020. PMID: 32712837 Review.
-
Inherited salt-losing tubulopathy: An old condition but a new category of tubulopathy.Pediatr Int. 2020 Apr;62(4):428-437. doi: 10.1111/ped.14089. Epub 2020 Apr 13. Pediatr Int. 2020. PMID: 31830341 Review.
Cited by
-
Untangling the Uncertain Role of Overactivation of the Renin-Angiotensin-Aldosterone System with the Aging Process Based on Sodium Wasting Human Models.Int J Mol Sci. 2024 Aug 28;25(17):9332. doi: 10.3390/ijms25179332. Int J Mol Sci. 2024. PMID: 39273282 Free PMC article. Review.
-
Concurrent Gitelman Syndrome and Hyperthyroidism: Diagnostic Challenges in a 51-Year-Old Patient.Am J Case Rep. 2024 Aug 30;25:e944909. doi: 10.12659/AJCR.944909. Am J Case Rep. 2024. PMID: 39210578 Free PMC article.
-
A triple SLC12A3 heterozygous mutations in Gitelman syndrome with renal calculi.Hippokratia. 2023 Apr-Jun;27(2):64-68. Hippokratia. 2023. PMID: 39056097 Free PMC article.
-
Chemotherapy-induced tubulopathy: a case report series.Front Nephrol. 2024 Apr 11;4:1384208. doi: 10.3389/fneph.2024.1384208. eCollection 2024. Front Nephrol. 2024. PMID: 38666245 Free PMC article.
-
Gitelman syndrome and in vitro fertilization-embryo transfer: advancing preconception care in nephrology.CEN Case Rep. 2024 Apr 17. doi: 10.1007/s13730-024-00872-4. Online ahead of print. CEN Case Rep. 2024. PMID: 38630244
References
-
- Kurtz I. Molecular pathogenesis of Bartter's and Gitelman's syndromes. Kidney Int. 1998;54:1396–1410. - PubMed
-
- Simon D.B., Nelson-Williams C., Bia M.J. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24–30. - PubMed
-
- Balavoine A.S., Bataille P., Vanhille P. Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome. Eur J Endocrinol. 2011;165:665–673. - PubMed
-
- Cruz D.N., Shaer A.J., Bia M.J. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 2001;59:710–717. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials